medigraphic.com
ENGLISH

Archivos de Medicina de Urgencia de México

ISSN 2594-3006 (Digital)
ISSN 2007-1752 (Impreso)
Archivos de Medicina de Urgencia de México
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2013, Número 1

<< Anterior Siguiente >>

Arch Med Urg Mex 2013; 5 (1)


El paciente inestable con tromboembolia pulmonar

Velázquez AJI, Russi HM, Loria CJ
Texto completo Cómo citar este artículo Artículos similares

Idioma: Español
Referencias bibliográficas: 85
Paginas: 25-37
Archivo PDF: 326.84 Kb.


PALABRAS CLAVE

Tromboembolia pulmonar, diagnóstico, tratamiento.

RESUMEN

El tromboembolismo pulmonar (TEP) es una entidad cardiopulmonar con una incidencia creciente y elevadas repercusiones clínicas, económicas y sociales. Un adecuado abordaje diagnóstico y terapéutico nos ofrecerá la oportunidad de atender de forma adecuada a estos pacientes.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Goldhaber SZ, Elliot CG. Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis. Circulation 2003; 108: 2726-2729.

  2. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registery (ICOPER). Lancet 1999; 353: 1386-1389.

  3. Kasper W, Konstantinides S, Geibel A et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registery. J Am Coll Cardiol 1997; 30: 1165-1171.

  4. Anderson FA Jr, Wheeler HB, Goldberg RJ et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-938.

  5. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-593.

  6. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J 1995; 130: 1276-1282.

  7. Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation. 2005; 112:e28-e32.

  8. Fengler BT, Brady WJ. Fibrinolytic therapy in pulmonary embolism : an evidence-based treatment algorithm. Am J Emerg Med 2009; 27: 84-95.

  9. Goldhaber SZ. Advanced treatment strategies for acute pulmonary embolism, including thrombolysis and embolectomy. J Thromb Haemost 2009; 7: 322-327.

  10. Goldhaber SZ, Haire WD, Feldstein ML et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-511.

  11. Kline JA, Zeitouni R, Marchick MR, Hernandez-Nino J, Rose GA. Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism. Am Heart J 2008; 156: 308-314.

  12. Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen. J Am Coll Cardiol 1987; 10: 971-978.

  13. Torbicki A, Perrier A, Konstantinides S et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2008; 29: 2276-2315.

  14. Kline JA, Steuerwald MT, Marchick MR et al. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Chest 2009; 136: 1202-1210.

  15. Nass N, McConnell MV, Goldhaber SZ et al. Recovery of regional right ventricular function after thrombolysis for pulmonary embolism. Am J Cardiol 1999; 83: 804-806, A10.

  16. Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 2004; 110: 744-749.

  17. Tapson VF. Acute pulmonary embolism. N Engl J Med 2008; 358: 1037-1052.

  18. Stein M, Levy SE. Reflex and humoral responses to pulmonary embolism. Prog Cardiovasc Dis 1974; 17: 167-174.

  19. Smulders YM. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 2000; 48: 23-33.

  20. Elliott CG. Pulmonary physiology during pulmonary embolism. Chest 1992; 101: 163S-171S.

  21. Wilson JE 3rd, Pierce AK, Johnson RL Jr et al. Hypoxemia in pulmonary embolism, a clinical study. J Clin Invest 1971; 50: 481-491.

  22. Tapson VF. Acute pulmonary embolism. Cardiol Clin 2004; 22: 353-365, v.

  23. Piazza G, Goldhaber SZ. The acutely descompensated right vetricle: pathways for diagnosis and management. Chest 2005; 128: 1836-1852.

  24. Brieke A, DeNofrio D. Right ventricular dysfunction in chronic dilated cardiomyopathy and heart failure. Coron Artery Dis 2005; 16: 5-11.

  25. Cecconi M, Johnston E, Rhodes A. What role does the right side of the heart play in circulation? Crit Care 2006; 10 (Suppl 3): S5.

  26. Goldstein JA. Pathophysiology and management of right heart ischemia. J Am Coll Cardiol 2002; 40: 841-853.

  27. Vieillard-Baron A, Page B, Augarde R et al. Acute Cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 2001; 27: 1481-1486.

  28. Louie EK, Lin SS, Reynertson SI et al. Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. Circulation 1995; 92: 819-824.

  29. Budev MM, Arroliga AC, Wiedemann HP, Matthay RA. Cor pulmonale: an overview. Semin Respir Crit Care Med 2003; 24: 233-244.

  30. Mebazaa A, Karpati P, Renaud E, Algotsson L. Acute right ventricular failure from pathophysiology to new treatments. Intensive Care Med 2004; 30: 185-196.

  31. Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pulmonary embolism. Circulation 2006; 113: 577-582.

  32. Daniel KR, Courtney DM, Kline JA. Assessment of cardiac stress from massive pulmonary embolism with 12-lead ECG. Chest 2001; 120: 474-481.

  33. Rogers RL, Winters M, Mayo P. Pulmonary embolism: remember that patient you saw last night? Emerg Med Pract 2004; 6: 1-18.

  34. Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am J Respir Crit Care Med 2008; 178: 425-430.

  35. Sanchez O, Trinquart L, Colombet I et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J 2008; 29: 1569-1577.

  36. Tapson VF. Diagnosing and managing acute pulmonary embolism: role of cardiac troponins. Am Heart J 2003; 145: 751-753.

  37. Scridon T, Scridon C, Skali H et al. Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol 2005; 96: 303-305.

  38. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116: 427-433.

  39. Elliott CG, Goldhaber SZ, Visani L, DeRosa M. Chest radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry. Chest 2000; 118: 33-38.

  40. Roy PM, Colombet I, Durieux P, Chatellier G, Sors H, Meyer G. Systematic review and metaanalysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ 2005; 331:259.

  41. Jones AE, Tayal VS, Sullivan DM, Kline JA. Randomized, controlled trial of inmediate versus delayed goal-directed ultrasound to identify the cause of nontraumatic hypotension in emergency department patients. Crit Care Med 2004; 321: 1703-1708.

  42. Jardin F, Dubourg O, Bourdarias JP. Echocardiographic pattern of acute Cor pulmonale. Chest 1997; 111: 209-217.

  43. Konstantinides S. Acute pulmonary embolism. N Engl J Med 2008; 359: 2804-2813.

  44. Otero R, Trujillo-Santos J. Cayuela A et al. Haemodynamically unstable pulmonary embolism in the RIETE Registery: systolic blood pressure of shock index? Eur Respir J 2007; 30: 1111-1116.

  45. Sanchez O, Planquette B, Meyer G. Update on acute pulmonary embolism. Eur Respir Rev 2009; 18: 137-147.

  46. Layish DT, Tapson VF. Pharmacologic hemodynamic support in massive pulmonary embolism. Chest 1997; 111: 218-224.

  47. Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H. Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 1999; 27: 540-544.

  48. Pastores SM. Management of venous thromboembolism in the Intensive Care Unit. J Crit Care 2009; 24: 185-191.

  49. Ghignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular after load in dogs. Anesthesiology 1984; 60: 132-135.

  50. Hauser CJ, Shoemaker WC. Volume loading in massive acute pulmonary embolus. Crit Care Med 1979; 7: 304-306.

  51. Belenkie I, Dani R, Smith ER, Tyberg JV. Effects of volumen loading during experimental acute pulmonary embolism. Circulation 1989; 80: 178-188.

  52. Belenkie I, Dani R, Smith ER, Tyberg JV. The importance of pericardial constraint in experimental pulmonary embolism and volumen loading. Am Heart J 1992; 123: 733-742.

  53. Molloy WD, Lee KY, Girling L et al. Treatment of shock in a canine model of pulmonary embolism. Am Rev Repair Dis 1984; 130: 870-874.

  54. Mathru M, Venus B, Smith RA et al. Treatment of low cardiac output complicating acute pulmonary hypertension in normovolemic goats. Crit Care Med 1986; 14: 120-124.

  55. Tanaka H, Tajimi K, Matsumoto A, Kobayashi K. Vasodilatory effects of milrinone on pulmonary vasculature in dogs with pulmonary hypertension due to pulmonary embolism: a comparison with those of dopamine and dobutamine. Clin Exp Pharmacol Physiol 1990; 17: 681-690.

  56. Wood KE. Major pulmonary embolism: of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121: 877-905.

  57. de Boisblanc BP. Treatment of massive pulmonary embolism. Clin Pulm Med 1995; 2: 353-358.

  58. Michard F, Reuter DA. Assessing cardiac preload or fluid responsiveness? It depends on the question we want to answer. Intensive Care Med 2003; 29: 1396.

  59. Bendjelid K, Romand JA. Fluid responsiveness in mechanically ventilated patients: a review of indices used in intensive care. Intensive Care Med 2003; 29: 352-360.

  60. Michard F, Teboul JL. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest 2002; 121: 2000-2008.

  61. Viires N, Sillye G, Aubier M, Rassidakis A, Roussos C. Regional blood flow distribution in dog during induced hypotension and low cardiac output. Spontaneousbreathing versus artificial ventilation. J Clin Invest 1983; 72: 935-947.

  62. Jardin F, Vieillard-Baron A. Right ventricular function and positive pressure ventilation in clinical practice: from hemodynamic subsets to respirator settings. Intensive Care Med 2003; 29: 1426-1434.

  63. Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: I. Anatomy, physiology, and assessment. Anesth Analg 2009; 108: 407-421.

  64. Lee FA. Hemodynamics of the right ventricle in normal and disease states. Cardiol Clin 1992; 10: 59-67.

  65. Angle MR, Molloy DW, Penner B et al. The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolism. Chest 1989; 95: 1333-1337.

  66. Hirsch LJ, Rooney MW, Wat SS et al. Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism. Chest 1991; 100: 796-801.

  67. Boulain T, Lanotte R, Legras A, Perrotin D. Efficacy of epinephrine therapy in shock complicating pulmonary embolism. Chest 1993; 104: 300-302.

  68. Gold J, Cullinane S, Chen J et al. Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. Am J Cardiol 2000; 85: 506-508.

  69. Ellender TJ, Skinner JC. The use of vasopressors and inotropes in the emergency medical treatment of shock. Emerg Med Clin North Am 2008; 26: 759-786.

  70. Halmagyi DF, Colebatch HJ, Starzecki B et al. Effect of isoproterenol in “severe” experimental lung embolism with and without postembolic collapse. Am Heart J 1963; 65: 208-219.

  71. Molloy DW, Lee KY, Jones D et al. Effects of noradrenaline and isoproterenol on cardiopulmonary function in a canine model of acute pulmonary hypertension. Chest 1985; 88: 432-435.

  72. Wolfe MW, Saad RM, Spence TH. Hemodynamic effects of amrinone in a canine model of massive pulmonary embolism. Chest 1992; 102: 274-278.

  73. Rosenberg JC, Hussain R, Lenaghan R. Isoproterenol and norepinephrine therapy for pulmonary embolism shock. J Thorac Cardiovasc Surg 1971; 62: 144-150.

  74. Spence TH, Newton WD. Pulmonary embolism: improvement in hemodynamic function with amrinone therapy. South Med J 1989; 82: 1267-1268.

  75. Ducas J, Duval D, Dasilva H et al. Treatment of canine pulmonary hypertension: effects of norepinephrine and isoproterenol on pulmonary vascular pressure-flow characteristics. Circulation 1987; 75: 235-242.

  76. Jardin F, Genevray B, Brun-Ney D, Margairaz A. Dobutamine: a hemodynamic evaluation in pulmonary embolism shock. Crit Care Med 1985; 13: 1009-1012.

  77. Prewitt RM. Hemodynamic management in pulmonary embolism and acute hypoxemic respiratory failure. Crit Care Med 1990; 18: S61-S69.

  78. Woods J, Monteiro P, Rhodes A. Right ventricular dysfunction. Curr Opin Crit Care 2007; 13: 532-540.

  79. Fattouch K, Sbraga F, Bianco G et al. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement. J Card Surg 2005; 20: 171-176.

  80. Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med 2004; 140: 175-183.

  81. Capstick T, Henry MT. Efficacy of thrombolytic agents in the treatment of pulmonary embolism. Eur Respir J 2005; 26: 864-874.

  82. Kearon C, Kahn SR, Agnelli G et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008; 133: 454S-545S.

  83. Ellender TJ, Mihata GK, Skinner JCR. The unstable patient with pulmonary embolism. Emergency Department Resuscitation of the Criticalle Ill. ACEP. 2011: 87-96.

  84. Criner GJ, Barnette RE, D’Alonzo GE. Management of massive pulmonary embolism. Critical Care Study Guide Text and Review, 2nd ed. 205-319, 2010.

  85. Torbicki Adam, Perrier Arnaud, Stavros Konstantinides, Giancarlo Agnelli, Nazzareno Galiè et al. Guías de Práctica Clínica de la Sociedad Europea de Cardiología. Guías de práctica clínica sobre diagnóstico y manejo del tromboembolismo pulmonar agudo. Rev Esp Cardiol 2008; 61 (12): 1330.e1-1330.e52.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Med Urg Mex. 2013;5

ARTíCULOS SIMILARES

CARGANDO ...